Integra LifeSciences Reports Second Quarter 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Integra LifeSciences Reports Second Quarter 2018 Financial Results

Integra LifeSciences (IART) Reports In-Line Q2 EPS, Revenues Miss; Boosts FY18 EPS/Revenue Mid-Point Outlooks Below Consensus

July 25, 2018 6:11 AM EDT

Integra LifeSciences (NASDAQ: IART) reported Q2 EPS of $0.60, in-line with the analyst estimate of $0.60. Revenue for the quarter came in at $366.2 million versus the consensus estimate of $368.25 million.

Revenue Increased 29.8% to $366.2 million; Organic Revenue Increased 3.4% Reported EPS of $0.14; Adjusted EPS of $0.60Raises Low-End of Full-Year Total Revenue and EPS GuidanceSuccessfully Exits First Wave of Codman Transition Services Agreements

Second Quarter 2018 Consolidated Results

Reported revenue was $366.2 million, an increase of 29.8% compared to the second quarter of 2017;... More